These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 9316771

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
    Kretowski A, Kowalska I, Peczyńska J, Urban M, Kinalska I.
    Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
    [Abstract] [Full Text] [Related]

  • 4. [Latent autoimmune (Type-1) diabetes mellitus in adults. Part. I. Serologic markers of autoimmune involvement of pancreatic beta-cells: GADA, ICA, IA-2 a IA-A].
    Martinka E, Ocenásová A, Straková J, Mokán M.
    Vnitr Lek; 1999 Feb; 45(2):97-102. PubMed ID: 15641228
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Antibodies to glutamic acid decarboxylase (GADA) as markers of risk for development of insulin-dependent diabetes mellitus].
    Kretowski A, Szelachowska M, Kowalska I, Peczyńska J, Urban M, Kinalska I.
    Przegl Lek; 1998 Feb; 55(6):315-9. PubMed ID: 9857706
    [Abstract] [Full Text] [Related]

  • 7. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
    Westerlund A, Ankelo M, Ilonen J, Knip M, Simell O, Hinkkanen AE.
    J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
    [Abstract] [Full Text] [Related]

  • 8. Pancreatic autoantibodies in Italian patients with newly diagnosed type 1 diabetes mellitus over the age of 20 years.
    Betterle C, Lazzarotto F, Fusari A, Zanchetta R, Benedini S, Pedini B, Moscon A, Presotto F.
    Acta Diabetol; 2006 Nov; 43(3):79-83. PubMed ID: 17143785
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
    Dittler J, Seidel D, Schenker M, Ziegler AG.
    Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692
    [Abstract] [Full Text] [Related]

  • 15. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.
    Kasuga A, Maruyama T, Nakamoto S, Ozawa Y, Suzuki Y, Saruta T.
    J Autoimmun; 1999 Mar; 12(2):131-5. PubMed ID: 10047433
    [Abstract] [Full Text] [Related]

  • 16. Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome.
    Morgenthaler NG, Seissler J, Achenbach P, Glawe D, Payton M, Meinck HM, Christie MR, Scherbaum WA.
    Autoimmunity; 1997 Mar; 25(4):203-11. PubMed ID: 9344328
    [Abstract] [Full Text] [Related]

  • 17. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM, Deschamps I, Garchon HJ, Roussely H, Moreau N, Beaurain G, Robert JJ, Bach JF.
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [Abstract] [Full Text] [Related]

  • 18. The use of immunological markers in IDDM after more than 20 years from ICA description.
    Dotta F, Dionisi S, Farilla L, Di Mario U.
    Diabetes Metab Rev; 1996 Jul; 12(2):121-6. PubMed ID: 8877281
    [No Abstract] [Full Text] [Related]

  • 19. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
    Seissler J, Morgenthaler NG, Achenbach P, Lampeter EF, Glawe D, Payton M, Christie M, Scherbaum WA.
    Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
    [Abstract] [Full Text] [Related]

  • 20. MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus.
    Gupta M, Graham J, McNeeny B, Zarghami M, Landin-Olsson M, Hagopian WA, Palmer J, Lernmark A, Sanjeevi CB.
    Ann N Y Acad Sci; 2006 Oct; 1079():229-39. PubMed ID: 17130560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.